All In Biotech

Drug Trial Radar · NCT07553442

A Study to Evaluate ALN-AGT01 RVR in Adult Patients With Mild to Moderate Hypertension Pretreated With Zilebesiran

A Phase 2, Randomized, Double-blind, Placebo-controlled, Single Dose Study of the Efficacy, Pharmacodynamics, and Safety of ALN-AGT01 RVR in Adult Patients With Mild to Moderate Hypertension Pretreated With Zilebesiran

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

93

Planned (sponsor's estimate)

Start

Apr 27, 2026

Primary completion

Apr 1, 2028

Study completion Oct 1, 2028

Sponsor

Lead sponsor
Alnylam PharmaceuticalsAlnylam Pharmaceuticals (ALNY)
Sponsor type
Industry
Collaborators
Hoffmann-La Roche
First posted
Apr 28, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy, pharmacodynamics (PD), and safety of ALN-AGT01 RVR in participants with mild to moderate hypertension pretreated with zilebesiran.

Conditions

  • Hypertension

Interventions

  • ALN-AGT01 RVRDrug

    ALN-AGT01 RVR will be administered subcutaneously (SC)

  • PlaceboDrug

    Placebo will be administered SC

  • ZilebesiranDrug

    Zilebesiran will be administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Part A: Percentage recovery from baseline in serum AGTTime frame: Up to Day 4
  2. Part B: Percentage recovery from baseline in mean seated office SBPTime frame: At Day 4 and Day 7

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Clinical Trial Site

    Lake Forest, California · Recruiting

  • Clinical Trial Site

    Tampa, Florida · Active not recruiting

  • Clinical Trial Site

    Savannah, Georgia · Active not recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.